Completed OBSERVATIONAL NCT05184153
Medullary Colonic Carcinoma (MEDCCR)
Sponsor: University Hospital, Limoges
Updated 3 times since 2022 Last updated: Jan 7, 2022 Started: Mar 3, 2020 Primary completion: Dec 19, 2020 Completion: Sep 1, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Medullary Carcinoma of Colon and Prognostic Factors and is currently completed. University Hospital, Limoges leads this study, which shows 3 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2022 — Jul 2024 [monthly]
Completed
First recorded
Mar 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University Hospital, Limoges
Data source: University Hospital, Limoges
For direct contact, visit the study record on ClinicalTrials.gov .